Avene

Hydrance Crème Hydratante Riche, 40ml

Name: Hydrance Crème Hydratante Riche, 40ml
Brand: Avene

Rich moisturizing cream for sensitive, dry to very dry skin. Intensely nourishes, soothes sensations of discomfort, and restores vitality to the face.

Safety

True or false, at a glance

Free from CMR-classified ingredients?

Contains: Cyclométhicone

Free from endocrine disruptors?

Contains: Cyclométhicone, Butylhydroxytoluène

Free from fragrance allergens (Annex III)?

To be confirmed

Composition incomplete on our side : absence not guaranteed.

Fragrance-free?

Contains: Parfum

This rich moisturizing cream is formulated for sensitive, dry to very dry skin. Enriched with Eau Thermale d'Avène and shea butter, its creamy texture intensely nourishes the epidermis, soothes sensations of tightness and discomfort, and helps the skin regain hydration and vitality. It is applied to the face for immediate comfort.

Ingredients

Composition

Huile de paraffineSkin conditioning GlycérineSkin conditioning PPG-15 Stearyl EtherSkin conditioning CyclométhiconeSkin conditioning Alcool cétéaryliqueSkin conditioning Huile de carthameSkin conditioning Stéarate de glycéryleSkin conditioning Stéarate de PEG-100Surfactant Beurre de karitéSkin conditioning Cétéaryl polyglucosideSurfactant Acide benzoïquePerfuming Bêta-sitostérolSkin conditioning ButylhydroxytoluènePerfuming Isoparaffine C13-14Skin conditioning Triglycéride caprylique/capriqueSkin conditioning ChlorphénésinePreservative EDTA disodiquePerfuming ParfumPerfuming Extrait de graines de sojaSkin conditioning Glycérides de coco hydrogénésSkin conditioning Laureth-7Perfuming LécithineSkin conditioning PEG-32Perfuming PEG-400Perfuming PhénoxyéthanolPreservative Poloxamère 188Surfactant PolyacrylamideHair conditioning Sulfate de chondroïtine sodiqueSkin conditioning Hydroxyde de sodiumPerfuming EauSolvent Gomme xanthaneSkin conditioning

No contraindication is on record for the ingredients of this product. If in doubt, ask your pharmacist.

Regulatory framework

What the authorities say

Authority	Status
Commission européenne (CosIng, Règl. 1223/2009) — via Cyclométhicone	Interdit (Annexe II) — Octamethylcyclotetrasiloxane; D4
Classification CLP (Règl. 1272/2008) — via Cyclométhicone	Reprotoxique — suspecté
ECHA — perturbateur endocrinien (santé humaine) — via Cyclométhicone	Perturbateur endocrinien — suspecté
ECHA — perturbateur endocrinien (santé humaine) — via Butylhydroxytoluène	Perturbateur endocrinien — suspecté